Diagnosis and treatment of right ventricular metastasis from esophageal squamous cell carcinoma: An unusual case report and a literature review
Lingyun Luo,Xuelian Luo
DOI: https://doi.org/10.1097/md.0000000000036404
IF: 1.6
2024-02-23
Medicine
Abstract:The incidence of cardiac metastatic tumors is up to 40 times higher than that of primary tumors. [ 1 ] What is more, cardiac metastatic tumors are often asymptomatic that they are found only at autopsy and seldom be reported. [ 2 ] Mainly malignant melanoma and primary mediastinal tumors, but also lymphoma, lung carcinoma, breast, esophagus, and leukemia, are cause of cardiac metastases. [ 3 ] In case of cardiac metastatic tumors, the prognosis is poor and therapeutic options limited. [ 4 ] Generally, patients with symptomatic heart metastases die within a few weeks, with a median survival of 4 weeks. [ 5–7 ] Malignant tumors can metastasize to the heart through 3 pathways: direct infiltration; blood diffusion; lymphatic spread. Direct invasion of mediastinum and intrathoracic tumors often leads to pericardial metastasis; Blood dissemination usually causes myocardial metastasis; Lymphatic spread often causes pericardial metastasis. Endocardial metastasis is relatively rare, usually caused by blood invading tumor cells entering the ventricular cavity, and can also be secondary to myocardial metastasis. [ 8 ] Tumors spread can occur, in descending order, to the pericardium, myocardium, epicardium, endocardium and less frequently to the intracavitary regions with predominance to the right-side of the heart. [ 9 ] We report a case of right ventricular metastasis from esophageal squamous cell carcinoma with relatively good prognosis. Presently, there is a lack of standard treatment methods for cardiac metastatic tumors. According to literature reports, the therapy is mainly targeted at the treatment of metastasis tumor, such as undergoing cardiac metastatic tumor resection. Surgery can relieve obstruction and alleviate patient symptoms, as well as diagnosis the nature of cardiac tumors. The patient we reported got relief after the early surgery and chemotherapy. Unfortunately, the COVID-19 broke and the patient died on Dec 19th, 2022. This patient took about 6 months from the diagnosis of cardiac metastasis to death, which far exceeded the median survival period of 4 weeks reported in previous literature. Considering the rarity of cardiac metastases and the current lack of effective treatment measures, we will report on the patient diagnosis and treatment process and share our treatment measures in the hope of providing valuable insights for the treatment of cardiac metastases.
medicine, general & internal